Read + Share
Amedeo Smart
Independent Medical Education
Le X, Nilsson M, Goldman J, Reck M, et al. Dual EGFR-VEGF Pathway Inhibition: A Promising Strategy for Patients With EGFR-Mutant NSCLC. J Thorac Oncol 2021;16:205-215.PMID: 33096270
Email
LinkedIn
Facebook
Twitter
Privacy Policy